Free Trial
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel
NASDAQ:STIM

Neuronetics Q3 2026 Earnings Date & Estimates

Neuronetics logo
$2.13 -0.01 (-0.47%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$2.16 +0.03 (+1.46%)
As of 10/9/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Neuronetics is scheduled to report Q3 2026 earnings on Tuesday, November 3, 2026, before market opens. The conference call is scheduled for 8:30 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
8:30 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Neuronetics in Q3 2026

Neuronetics is expected to post earnings of -$0.08 per share on revenue of $40.43 million. In the same quarter a year earlier Neuronetics reported -$0.13 per share on revenue of $37.30 million. Neuronetics last reported on August 11, 2026, posting -$0.05 per share and beating the -$0.1230 consensus estimate. Neuronetics has beaten the consensus EPS estimate in 4 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.08
Expected Revenue
$40.43 million
Prior-Year EPS
-$0.13
Prior-Year Revenue
$37.30 million
Expected Revenue Growth
+8.4%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.05 (Beat by +$0.0730)
Last Quarter Revenue
$41.57 million
EPS Beat Rate
4 of last 8 quarters

Prepare for the Q3 2026 Call

Neuronetics Q3 2026 Earnings FAQ

Neuronetics (NASDAQ:STIM) is scheduled to report Q3 2026 earnings on Tuesday, November 3, 2026, before market opens.

Neuronetics' Q3 2026 earnings conference call is scheduled for Tuesday, November 3, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Neuronetics to post earnings of -$0.08 per share for Q3 2026.

The consensus revenue estimate for Neuronetics is $40.43 million for Q3 2026.

Neuronetics Earnings Headlines

Neuronetics, Inc. (NASDAQ:STIM) Stock Has Average Target Price of $4.67 According to Brokerages
October 6, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31091268
B Riley Securities initiates coverage of Neuronetics at buy
September 12, 2026  |  msn.comhttps://www.msn.com/en-us/money/economy/b-riley-securities-initiates-coverage-of-neuronetics-at-buy/ar-AA2c4hDW
The Executive Order That Quietly Changed What Your Dollar Means
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel
October 11 at 1:00 AM  |  Reagan Gold Group (Ad)
B. Riley Initiates Neuronetics at Buy With $5 Price Target
September 11, 2026  |  marketscreener.comM
NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System
September 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/08/3357668/0/en/neurostar-advances-practice-innovation-with-first-ever-tms-integration-with-an-ehr-emr-system.html
Neuronetics (STIM) Q2 2026 Earnings Call Transcript
August 18, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/neuronetics-stim-q2-2026-earnings-154322384.html
See More Neuronetics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Neuronetics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Neuronetics and other key companies, straight to your email.

About Neuronetics

Neuronetics (NASDAQ:STIM) is a medical technology company focused on developing and commercializing noninvasive treatments for mental health conditions. The company’s primary product is the NeuroStar Advanced Therapy system, which uses transcranial magnetic stimulation (TMS) to deliver targeted magnetic pulses to areas of the brain associated with mood and related symptoms.

NeuroStar TMS Therapy is cleared by the U.S. Food and Drug Administration for the treatment of major depressive disorder in adults and adolescents, obsessive-compulsive disorder in adults, and certain associated indications. The treatment is administered in a clinical setting and is designed to provide an alternative or complement to medication-based approaches.

Founded in 2003 and headquartered in Malvern, Pennsylvania, Neuronetics markets its systems and related services primarily through a network of healthcare providers and treatment centers. The company also supports providers with treatment-planning resources, patient engagement tools and practice-development services intended to expand access to its neurostimulation therapies.

View Neuronetics Profile
Earnings Tools